These results suggest that hPSC-BC and more specifically hPSC-BC-CD144+CD45+ have the potential to generate multilineage hematopoiesis contrary to hPSC-EB-CD144+ that were only enriched in terms involved in erythroid, myeloid and megakaryocytic lineages (see Additional file 18: Table S9). The gene discussed is PTPRC; the disease is breast cancer.